[
  {
    "ts": null,
    "headline": "Waters Corp. stock outperforms competitors on strong trading day",
    "summary": "Waters Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=9f75d681ab62710fe61b52df78131ec48f9a94091369c65cd0088a4ce3f3eb4f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760375160,
      "headline": "Waters Corp. stock outperforms competitors on strong trading day",
      "id": 137118911,
      "image": "",
      "related": "WAT",
      "source": "MarketWatch",
      "summary": "Waters Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=9f75d681ab62710fe61b52df78131ec48f9a94091369c65cd0088a4ce3f3eb4f"
    }
  },
  {
    "ts": null,
    "headline": "Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics",
    "summary": "Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterization for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology. With the rapid growth of cell and gene therapies, mRNA, and complex protein therapeutics, scientists face significant challenges in analyzing increasingly large and heterogeneous drug modalities – yet existing tools are limited",
    "url": "https://finnhub.io/api/news?id=0d8f4c599850ec3c4822468b6287073511db1c91ad40168c65f8df7be8d3652f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760356800,
      "headline": "Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics",
      "id": 137066564,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Waters Corporation (NYSE: WAT) today unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterization for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology. With the rapid growth of cell and gene therapies, mRNA, and complex protein therapeutics, scientists face significant challenges in analyzing increasingly large and heterogeneous drug modalities – yet existing tools are limited",
      "url": "https://finnhub.io/api/news?id=0d8f4c599850ec3c4822468b6287073511db1c91ad40168c65f8df7be8d3652f"
    }
  }
]